首页> 外文期刊>Carbohydrate research >Synthesis of neoglycoproteins containing D-glycero-D-talo-oct-2-ulopyranosylonic acid (Ko) ligands corresponding to core units from Burkholderia and Acinetobacter lipopolysaccharide
【24h】

Synthesis of neoglycoproteins containing D-glycero-D-talo-oct-2-ulopyranosylonic acid (Ko) ligands corresponding to core units from Burkholderia and Acinetobacter lipopolysaccharide

机译:包含与Burkholderia和不动杆菌脂多糖核心单元相对应的D-甘油-D-talo-oct-2-ulopyranosylonic酸(Ko)配体的新糖蛋白的合成

获取原文
获取原文并翻译 | 示例
           

摘要

Glycal esters of Kdo derivatives were converted into 2,3-anhydro intermediates, which were transformed into D-glycero-D-talo-oct-2-ulopyranosylonic acid (Ko), as well as 3-O- and 4-O-p-nitrobenzoyl-Ko derivatives. The exo-allyl orthoester derivative, methyl {5,7,8-tri-O-acetyl-4-O-(4-nitrobenzoyl)-2,3-O-[(1-exo-allyloxy)-ethyliden e]-D-glycero-beta -D-talo-oct-2-ulopyranos}onate, prepared from the 4-O-pNBz-protected Ko derivative, was elaborated into the alpha -Ko allyl ketoside, the reducing disaccharide alpha -Kdop-(2 --> 4)-Ko and the disaccharide alpha -Kdop-(2 --> 4)-Kop-(2 -->, OAll). Conversely, methyl[4, 5,7,8-tetra-O-acetyl-3-O-(4-nitrobenzoyl)-alpha -D-glycero-D-talo-2-octulopyranosyl bromide]onate [Carbohydr. Res., 244 (1993) 69-84], was coupled with a Kdo acceptor to give the disaccharide alpha -Kop-(2 -->4)-Kdop-(2 --> OAll) after orthoester rearrangement and deprotection. The allyl glycosides were treated with cysteamine and converted into neoglycoproteins. The ligands correspond to inner core units from Acinetobacter haemolyticus and Burkholderia cepacia lipopolysaccharides. (C) 2000 Elsevier Science Ltd. All rights reserved. [References: 22]
机译:将Kdo衍生物的乙二酸酯转化为2,3-脱水中间体,然后转化为D-甘油-D-talo-oct-2-ulyryranosylonic acid(Ko)以及3-O-和4-Op-硝基苯甲酰基-Ko衍生物。外烯丙基原酸酯衍生物,甲基{5,7,8-三-O-乙酰基-4-O-(4-硝基苯甲酰基)-2,3-O-[(1-外-烯丙氧基)-亚乙基e]-由4-O-pNBz保护的Ko衍生物制备的D-甘油-β-D-talo-oct-2-ulopyranos} onate精制为α-Ko烯丙基酮糖苷,还原性二糖α-Kdop-(2 -> 4)-Ko和二糖α-Kdop-(2-> 4)-Kop-(2->,OAll)。相反,[4,5,7,8-四-O-乙酰基-3-O-(4-硝基苯甲酰基)-α-D-甘油-D-talo-2-辛基吡喃糖基溴化]甲酸甲酯[碳水化合物。 Res。,244(1993)69-84]与Kdo受体偶联,在原酸酯重排和脱保护后得到二糖α-Kop-(2-→4)-Kdop-(2-→OAll)。用半胱胺处理烯丙基糖苷并转化为新糖蛋白。配体对应于溶血不动杆菌和洋葱伯克霍尔德菌脂多糖的内核单元。 (C)2000 Elsevier ScienceLtd。保留所有权利。 [参考:22]

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号